SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-026245
Filing Date
2020-09-11
Accepted
2020-09-11 16:17:21
Documents
15
Period of Report
2020-09-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea126768-8k_aikidopharma.htm 8-K 19348
2 PRESENTATION, DATED SEPTEMBER 11, 2020 ea126768ex99-1_aikidopharma.htm EX-99.1 17451
3 GRAPHIC ex99-1_001.jpg GRAPHIC 142093
4 GRAPHIC ex99-1_002.jpg GRAPHIC 246494
5 GRAPHIC ex99-1_003.jpg GRAPHIC 418055
6 GRAPHIC ex99-1_004.jpg GRAPHIC 338665
7 GRAPHIC ex99-1_005.jpg GRAPHIC 302724
8 GRAPHIC ex99-1_006.jpg GRAPHIC 291158
9 GRAPHIC ex99-1_007.jpg GRAPHIC 355215
10 GRAPHIC ex99-1_008.jpg GRAPHIC 291219
11 GRAPHIC ex99-1_009.jpg GRAPHIC 371526
12 GRAPHIC ex99-1_010.jpg GRAPHIC 218420
13 GRAPHIC ex99-1_011.jpg GRAPHIC 194343
14 GRAPHIC ex99-1_012.jpg GRAPHIC 179862
15 GRAPHIC ex99-1_013.jpg GRAPHIC 122926
  Complete submission text file 0001213900-20-026245.txt   4453847
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Aikido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 201171130
SIC: 8731 Services-Commercial Physical & Biological Research